A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study

Joseph Chao, Timothy W. Synold, Robert J. Morgan, Charles A. Kunos, Jeff Longmate, Heinz-Josef Lenz, Dean Lim, Stephen Shibata, Vincent Chung, Ronald G. Stoller,

Cancer Chemotherapy and Pharmacology · 2011 · 43 citations · 21 references

Concepts

References

21